Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy Vaccine [clinicaltrials:NCT00118625]

Bio2RDF uri

Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy Vaccine [clinicaltrials:NCT00118625]

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

http://bio2rdf.org/clinicaltrials:NCT00118625

Bio2RDF identifier

NCT00118625

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT00118625

http://www.w3.org/2001/XMLSchema#string

identifiers.org URI

NCT00118625

authority [clinicaltrials_vocabulary:authority]

clinicaltrials_resource:d942c8692d257084abf3ac87279faff6

brief summary [clinicaltrials_vocabulary:brief-summary]

Allergen-specific immun ...... h and hazel and alder pollen.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Assessment of the Contribution ...... a Tree Pollen Allergy Vaccine

http://www.w3.org/2001/XMLSchema#string

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

immunological response to Tree MATA MPL versus Tree MATA (birch specific) [clinicaltrials_resource:c4f1ec0db3f40649a846bfd0c07958f7]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

immunological response to Tree MATA MPL versus Tree MATA (birch specific) [clinicaltrials_resource:2ee102ee2cca7c81ea2e5bebce6aef6e]

immunological response to Tree MATA MPL versus Tree MATA (birch specific) [clinicaltrials_resource:5067b1e346ab1387c2073d7f0d92aec1]

immunological response to Tree MATA MPL versus Tree MATA (birch specific) [clinicaltrials_resource:5817d3729dd15f204c37fbae2783b723]

immunological response to Tree MATA MPL versus Tree MATA (birch specific) [clinicaltrials_resource:7c5980ad5f119875e7bbe736cc43e7ce]

immunological response to Tree MATA MPL versus Tree MATA (birch specific) [clinicaltrials_resource:8dd5d7ac4c31d864f4b6ca80f87e63ce]

immunological response to Tree MATA MPL versus Tree MATA (birch specific) [clinicaltrials_resource:95fccfe040af8855d705fa2c5c532a78]

immunological response to Tree MATA MPL versus Tree MATA (birch specific) [clinicaltrials_resource:97f8bcbdd2648d0b995370fc223511a6]

immunological response to Tree MATA MPL versus Tree MATA (birch specific) [clinicaltrials_resource:f4f5680303457096dbbe492eb9a67a73]

immunological response to Tree MATA MPL versus Tree MATA (birch specific) [clinicaltrials_resource:f519ea29ab4783871bc017f02919a33a]

immunological response to Tree MATA MPL versus Tree MATA (birch specific) [clinicaltrials_resource:fbd6bf2cc4d625e3d2aeb06b6574c762]

completion date [clinicaltrials_vocabulary:completion-date]

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

detailed description [clinicaltrials_vocabulary:detailed-description]

Allergic rhinitis is a ...... h and hazel and alder pollen.

http://www.w3.org/2001/XMLSchema#string

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT00118625 [clinicaltrials_resource:258676b36dd17c1563c552125ff08f3f]

enrollment [clinicaltrials_vocabulary:enrollment]

http://www.w3.org/2001/XMLSchema#integer

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

intervention [clinicaltrials_vocabulary:intervention]

Tree MATA MPL [clinicaltrials_resource:2c262f2edf97ee56849f6d0a96e494bd]

keyword [clinicaltrials_vocabulary:keyword]

Adjuvant

http://www.w3.org/2001/XMLSchema#string

Allergenicity

http://www.w3.org/2001/XMLSchema#string

Allergy Vaccination

http://www.w3.org/2001/XMLSchema#string

Allergy

http://www.w3.org/2001/XMLSchema#string

Specific Immunotherapy

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2010-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

Allergy Therapeutics [clinicaltrials_resource:005444bc20c36c68273c687acdaba059]

location [clinicaltrials_vocabulary:location]

Allied Research International Inc. [clinicaltrials_resource:d6562925e13f4d5e86a8dd9f6034dd63]

nct id [clinicaltrials_vocabulary:nct-id]

NCT00118625

http://www.w3.org/2001/XMLSchema#string

official title [clinicaltrials_vocabulary:official-title]

A Double-Blind Phase IIa Study ...... rch and Hazel and Alder Pollen

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

TreeMATAMPL202

http://www.w3.org/2001/XMLSchema#string

overall official [clinicaltrials_vocabulary:overall-official]

Deepen Patel, MD [clinicaltrials_resource:e8202e60f9e1b09fdec78d40d7a0fac0]

overall status [clinicaltrials_vocabulary:overall-status]

Completed [clinicaltrials_resource:07ca5050e697392c9ed47e6453f1453f]

oversight [clinicaltrials_vocabulary:oversight]

United States: Food and Drug Administration [clinicaltrials_resource:73751d8a5ea52e3a1fc17f6de719a047]

phase [clinicaltrials_vocabulary:phase]

Phase 2 [clinicaltrials_resource:56e0338b27a2d68f77402c88327b3f8d]

secondary id [clinicaltrials_vocabulary:secondary-id]

P2DP05002

http://www.w3.org/2001/XMLSchema#string

source [clinicaltrials_vocabulary:source]

Allergy Therapeutics [clinicaltrials_resource:005444bc20c36c68273c687acdaba059]

start date [clinicaltrials_vocabulary:start-date]

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT00118625 study design [clinicaltrials_resource:06f6ed8b56715c3c6f9d9f91ad812364]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT00118625

verification date [clinicaltrials_vocabulary:verification-date]

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT00118625

http://www.w3.org/2001/XMLSchema#string

title

Assessment of the Contribution ...... a Tree Pollen Allergy Vaccine

@en

inDataset

clinicaltrials_resource:bio2rdf.dataset.clinicaltrials.R3

type

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

label

Assessment of the Contribution ...... e [clinicaltrials:NCT00118625]

@en